Literature DB >> 1655002

Antigen receptor-mediated phosphoinositide hydrolysis in murine T cells is not initiated via G-protein activation.

R J Phillips1, M M Harnett, G G Klaus.   

Abstract

Ligation of the antigen receptors on both T and B lymphocytes induces phosphoinositide (PI) hydrolysis, Ca(2+)-mobilization and protein kinase C activation. The activation of the phosphoinositide-specific phosphodiesterase (PPI-PDE) following crosslinking of surface Ig receptors on B cells is controlled by an uncharacterized guanine nucleotide-regulatory (G) protein. Here we have used permeabilized murine T cells (both resting T cells and a conalbumin-specific CD4-positive T cell clone) to investigate a role for G protein(s) in coupling the TCR to the PPI-PDE. We found that anti-TCR McAb (or processed antigen)-induced PI hydrolysis cannot be uncoupled by permeabilizing T cells, as occurs with classical G protein-linked receptors. Furthermore, the TCR-mediated release of inositol phosphates in permeabilized T cells was not enhanced by non-hydrolyzable analogs of GTP, nor inhibited by GDP analogs. These findings therefore argue strongly against the concept that TCR-mediated PI hydrolysis is G-protein controlled.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655002     DOI: 10.1093/intimm/3.7.617

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  3 in total

1.  The antigen receptors on mature and immature T lymphocytes are coupled to phosphatidylcholine-specific phospholipase D activation.

Authors:  P A Reid; S D Gardner; D M Williams; M M Harnett
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

Review 2.  Cellular signalling mechanisms in B lymphocytes.

Authors:  W Cushley; M M Harnett
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

3.  Functional localization of an exocytosis-triggering G-protein in human cytotoxic T lymphocytes.

Authors:  H W Mittrücker; B Fleischer
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.